Analysts anticipate breakeven for Sanara MedTech within a ye...
Analysts anticipate breakeven for Sanara MedTech within a year, indicating bullish outlook. The prospects hinge on company's maintenance of robust 225% annual growth rate. The firm's low debt, majorly equity-funded, reduces investment risk.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000003007f564657fff.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment